BioLineRx Ltd.
USD3.15
+0.05 (+1.70%)
CEO
Philip A. Serlin
IPO Date
2011-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$3.06
Prev. Close
$3.10
Day Low
$3.06
Day High
$3.25
52W Low
$2.15
52W High
$5.06
Market Cap
$0.01B
Volume
0.00M
| -2.3 |
| 31 Dec 2023 | FY | 23.1% | -1262.8% | -458.4% | -94.8% | 0.88 | 1.10 | -1.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -40.8% | -27.2% | 0.24 | 4.87 | -1.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -41.3% | -34.6% | 0.07 | 5.91 | -3.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -140.4% | -65.4% | 0.35 | 2.15 | -1.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -80.3% | -50.0% | 0.31 | 2.36 | -0.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -55.6% | -40.8% | 0.21 | 4.74 | -2.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -46.1% | -39.9% | 0.00 | 7.49 | -4.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -45.2% | -40.7% | 0.01 | 9.86 | -3.3 |
| -2.3 |
| 30 Sept 2025 | Q3 | 80.3% | -228.8% | -5.0% | -2.5% | 0.58 | 2.09 | -4.2 |
| 30 Jun 2025 | Q2 | 76.3% | -1296.1% | -19.6% | -9.1% | 0.63 | 2.06 | -1.1 |
| 31 Mar 2025 | Q1 | 86.7% | 2010.6% | 24.6% | 11.8% | 0.66 | 2.27 | 0.4 |
| 31 Dec 2024 | Q4 | 48.2% | -27.1% | -23.7% | -8.2% | 1.12 | 1.76 | -1.7 |
| 30 Sept 2024 | Q3 | 83.4% | -117.8% | -68.5% | -11.0% | 3.48 | 1.52 | -2.2 |
| 30 Jun 2024 | Q2 | 83.4% | 9.0% | 3.5% | 0.7% | 2.24 | 1.61 | 25.1 |
| 31 Mar 2024 | Q1 | 78.8% | -10.2% | -5.3% | -1.3% | 0.87 | 1.14 | -25.4 |
| 31 Dec 2023 | Q4 | 23.1% | -289.3% | -105.0% | -21.7% | 0.88 | 1.53 | -2.1 |